Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

Camida has been honoured with the Pharma Supplier of the Year award at the Pharma Industry Awards 2024, recognising its pivotal role in supporting the global life sciences, industrial, and ingredient sectors through its specialised sourcing and supply capabilities.

Author: News Medical LS

Chan Zuckerberg Initiative (CZI) and NVIDIA expand collaboration to accelerate virtual cell model development, scaling biological data processing to petabytes, enhancing AI-powered tools, models, and datasets via CZI’s open Virtual Cells Platform.

Author: Irish News

ARC Regulator, Belfast-based precision medicine consultancy, expands into Asia to tap £260B life sciences market amid Western uncertainty, leveraging AI, regulatory expertise, and partnerships, following £3M Belfast lab and Derry hub investments.

Author: DCU

Prof. Silvia Giordani and Dr. Neil Conlon showcased nanomedicine and targeted cancer therapies at the Breakthrough Cancer Exhibition, highlighting Irish-led innovations in drug delivery, smart medicines, and patient-focused cancer research.

Author: by Jed Nykolle Harme

SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices.

Author: Jed Nykolle Harme

The pharmaceutical and life sciences industry is entering a transformative phase, characterised by strategic realignment and long-term investment in innovation. As global demand grows for advanced therapies and sustainable production, major players are reconfiguring operations to enhance efficiency and scientific output. SGS continues to empower professionals worldwide through its series of expert-led webinars, offering in-depth insights into evolving regulatory expectations, analytical testing challenges, and global industry best practices. The US Food and Drug Administration (FDA) has announced new measures to accelerate the approval of biosimilar medicines, generic versions of complex biologics engineered from living cells, marking a major shift in the pharmaceutical landscape. Meanwhile, Kuehne+Nagel named title sponsor for Pharma Industry Awards 2025 highlights how collaboration between healthcare logistics and life sciences continues to strengthen sector-wide innovation and recognition. These developments illustrate an industry balancing progress with precision, advancing innovation while ensuring global access and operational excellence. Stay connected to the ideas shaping the future of pharma, explore the full stories in this edition of our newsletter.

Author: Jed Nykolle Harme

The Pharma Industry Awards 2025 proudly welcomes Kuehne+Nagel Ireland as this year’s Title Sponsor, underscoring the company’s long-standing commitment to advancing excellence and innovation within the pharmaceutical and life sciences sectors.

Author: Contract Pharma

Bora Pharmaceuticals partners with Accord BioPharma to manufacture pre-filled syringes of UDENYCA at its Baltimore facility, expanding U.S. cancer care supply through advanced aseptic fill/finish capabilities.

Author: Bio Pharma Dive

Alkermes to acquire Avadel Pharmaceuticals for $2.1 billion, gaining sleep drug Lumryz and expanding into narcolepsy treatments; deal strengthens position in orexin-based therapies amid competition with Takeda’s oveporexton.

Author: Oceanographic Magazine

UCD leads €1.5M BRICONS project to restore Ireland’s native flat oyster reefs, in partnership with ATU, QUB, and TCD, aiming to boost biodiversity and coastal resilience under the Marine Institute’s Marine Research Programme.